Panagora Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Panagora Asset Management’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-67,872	Closed	-$115K	–	2576
2015 Q2	$115K	Sell	67,872 -101,906	-60%	-$173K	﹤0.01%	1910
2015 Q1	$236K	Buy	+169,778	New	+$236K	﹤0.01%	1614
2014 Q2	–	Sell	-485	Closed	-$1K	–	2497
2014 Q1	$1K	Buy	+485	New	+$1K	﹤0.01%	2330
2013 Q3	–	Sell	-360,251	Closed	-$800K	–	2487
2013 Q2	$800K	Buy	+360,251	New	+$800K	﹤0.01%	1145

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Panagora Asset Management's RXII Position: Q3 2015 in Review

Panagora Asset Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 67,872 shares — an estimated $115K sold.

Panagora Asset Management first reported a position in RXII in Q2 2013 and held it in 4 quarters. The position peaked at $800K in Q2 2013. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Panagora Asset Management reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Panagora Asset Management sold 67,872 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $115K.
Panagora Asset Management first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 4 quarters.
Panagora Asset Management's GALENA BIOPHARMA INC COM position peaked at $800K in Q2 2013.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Panagora Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.